Ignite Creation Date:
2024-05-05 @ 11:57 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00192049
Status:
COMPLETED
Last Update Posted:
2007-05-17
First Post:
2005-09-12
Brief Title:
A Randomized Study Comparing Single Agent Gemcitabine Intravesical Therapy Versus Mitomycin C in Patients With Intermediate Risk Superficial Bladder Cancer
Sponsor:
Organization:
Eli Lilly and Company